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Estrogen is a steroid hormone, which inﬂu-
ences the growth, differentiation, and function
of many target tissues. These include tissues of
the female and male reproductive systems such
as mammary gland, uterus, vagina, ovary,
testes, and prostate. Estrogens play an impor-
tant role in bone maintenance, in the central
nervous system, and in the cardiovascular sys-
tem (1). Estrogens are also involved in the
development of breast and endometrial can-
cers; in addition, they may have important
roles with regard to prostate and colon cancers
(2). The effects of estrogen are mediated by
two receptors: estrogen receptor α (ERα ) and
estrogen receptor β (ERβ ). Both receptors are
members of the superfamily of nuclear recep-
tors and have high degrees of homology in
their ligand-binding domains (LBDs) and
DNA-binding domains (DBDs) (3,4). ERα
and ERβ have similar afﬁnities for 17β -estra-
diol (E2), recognize a consensus DNA estro-
gen response element (ERE) located within
the regulatory region of target genes (4,5),
and are expressed in distinct and overlapping
tissues (6) as well as during human tumorige-
nesis (7). In the absence of hormone, the ER
resides in the nucleus of target cells where it is
associated with the heat-shock proteins hsp90
and hsp59 (8,9). The binding of E2 to ER is
followed by a conformational change, leading
to dissociation of the receptor from the heat-
shock proteins, formation of stable receptor
dimers (10), and subsequent interaction with
the ERE. The DNA-bound receptor can
then either positively or negatively regulate
target gene expression (11). Although the
precise mechanism by which the ER modu-
lates RNA polymerase activity remains to be
determined, the agonist-bound ER can
recruit accessory proteins that permit the
receptor to activate the transcriptional appa-
ratus (11–13). Conversely, when occupied
by antagonists, the ER either does not bind
ERE or the DNA-bound receptor associates
with corepressor proteins that repress tran-
scription (12).
The human diet contains several non-
steroidal estrogenic compounds, which are
structurally similar to natural and synthetic
estrogens and antiestrogens. Dietary estro-
gens are either produced by plants themselves
(phytoestrogens) or by fungi that infect
plants (mycoestrogens). Phytoestrogens can
be divided into three main classes: isoﬂavones
(such as genistein and daidzein), coumestans
(such as coumestrol), and lignans (such as
enterodiol and enterolactone) (Figure 1).
Soybeans and clover, as well as other
legumes, are the most signiﬁcant sources of
isoﬂavones and coumestans (14). In response
to pathogens and other stimuli, soybean tis-
sues accumulate the phytoalexin glyceollin,
which shares structural similarities with the
isoﬂavones (15). Mycoestogens include pri-
marily zearalenone (resorcylic acid lactone)
and its derivatives (14). Dietary intake of
phytoestrogens is significantly higher in
countries where the incidence of breast and
prostate cancers is low, suggesting that they
may act as chemopreventive agents (16). The
chemopreventive effect of dietary soy has
been demonstrated on the development of
induced mammary tumors in rodents (16).
Phytoestrogens are believed to exert their
chemopreventive action by interacting with
the ERs and thus modulate the transcription
of target genes, although alternative mecha-
nisms have also been proposed (14).
In this study we used ﬂuorescence polar-
ization (FP) to investigate the estrogenic
activity of isoflavones, coumestans, phy-
toalexins, and mycoestrogens in competition
binding assays with human ERα and ERβ .
We also investigated the ability of the lig-
anded receptors to interact with Xenopus
vitellogenin (vit) A2 ERE and human pS2
ERE in direct binding assay. 
FP is used to study molecular interactions
by detecting the changes in the effective mol-
ecular volume of fluorescent molecules
(17,18). When plane-polarized light is used
to excite a solution of ﬂuorescent molecules,
the molecules parallel to the plane become
excited. The molecules in solution tumble
during the period of excitation and thus the
emitted light is depolarized. The observed
polarization is a measure of the tumbling rate
of the fluorescent molecule and is directly
related to its molecular volume (17–19).
Changes in the molecular volume that result
from binding, dissociation, or conformation-
al changes are detected by FP. If a ﬂuorescent
molecule becomes bound to another mole-
cule, the larger complex will tumble slower
than the free ﬂuorescent molecule and high
polarization values will be measured. There
are several methods for measuring ligand–
receptor binding interactions (20,21), but we
chose FP because it can be run at room tem-
perature, requires only hours to complete,
involves no radioactivity, and can be used for
screening of weak estrogens with limited sol-
ubility (17,18).
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Epidemiologic and experimental studies support the hypothesis that dietary estrogens from plant
sources (phytoestrogens) may play a role in the prevention of breast and prostate cancer. The
molecular mechanisms for such chemopreventive effect are still unclear. We investigated the pos-
sibility that phytoestrogens may bind differentially to estrogen receptor proteins (ERα and ERβ )
and affect the interactions of the ligand–ER complexes with different estrogen response element
(ERE) sequences. We used ﬂuorescence polarization to measure the binding afﬁnities of genistein,
coumestrol, daidzein, glyceollin, and zearalenone for human ERα and ERβ . Competition binding
experiments revealed higher affinity of the phytoestrogens for ERβ than for ERα . Genistein
[median inhibitory concentration 12nM] is the most potent and has the same relative binding
afﬁnity for ERβ as 17β -estradiol. We also studied the effect of these phytoestrogens on the ability
of ERα and ERβ to associate with speciﬁc DNA sequences (EREs). The direct binding of human
recombinant estrogen receptors to fluorescein-labeled EREs indicates that phytoestrogens can
cause conformational changes in both human ERs, which results in altered afﬁnities of the com-
plexes for the ERE from the Xenopus vitellogenin A2 gene and an ERE from the human pS2
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Materials. The steroids E2 and testosterone
were obtained from Sigma Chemical Co.
(St. Louis, MO).
The phytoestrogens genistein (4´,5,7-tri-
hydroxyisoﬂavone), daidzein (4´,7-hydroxy-
isoflavone), coumestrol [2-(2-,4-dihydrox-
yphenyl)-6-hydroxy-3-benzofurancarboxylic
acid δ -lactone], and zearalenone [6-(10-
hydroxy-6-oxo-trans-1-undecenyl)-β -resor-
cyclic acid lactone] were purchased from
Indofine Chemical Company, Inc. (Belle
Mead, NJ). Glyceollin was obtained from the
U.S. Department of Agriculture Southern
Regional Research Center. 
Human recombinant estrogen receptors
α and β , and fluorescein-labeled E2 (ES2)
were purchased from Pan Vera Corporation
(Madison, WI). Fluorescein end-labeled
Xenopus vit A2, and human pS2 EREs and
glucocorticoid response elements (GRE)
were custom synthesized by Oligos Etc.
(Wilsonville, OR).
ES2–ER direct binding experiments.
Recombinant human ERα and ERβ
(PanVera Corporation) were serially diluted
from 256 nM to 0.5 nM in screening buffer
(100 mM potassium phosphate, pH 7.5;
100 µg/mL bovine gamma globulin; 0.02%
sodium azide) to a ﬁnal volume of 100 µL in
borosilicate test tubes. ES2 (fluorescein-
labeled E2) was added to each test tube to a
ﬁnal concentration of 1 nM and incubated
for 60 min at room temperature. The FP of
each tube was measured on a Beacon 2000
Fluorescence Polarization Instrument
(PanVera Corporation) with 490 nm excita-
tion filter and 530 nm emission filter
(18,19). FP values were plotted versus ER
concentration.
We used a nonlinear least-squares curve
ﬁtting program (Prizm; Graphpad Inc., San
Diego, CA) to calculate the dissociation con-
stant (Kd) as the concentration of ER at
which half of the ligand is bound. 
Competitive binding experiments. We
tested genistein, daidzein, coumestrol, glyce-
ollin, and zearalenone to determine their
ability to displace the ES2 molecule from
ERα –ES2 and ERβ –ES2 complexes.
We prepared serial dilutions of each
competing phytoestrogen from an 8 mM
ethanol stock solution in screening buffer.
Preincubated ERα or ERβ (13 nM) and ES2
(1 nM) were added to produce a ﬁnal volume
of 100 µL. After 60 min incubation at room
temperature, the polarization values at each
competitor’s concentration were measured
using the Beacon 2000 FP system with 490
nm excitation ﬁlter and 530 nm emission ﬁl-
ter. The polarization values were converted to
percent inhibition using the equation
I% = (P0–P)/(P0–P100) × 100,
where P0 is the polarization value at 0%
inhibition, P100 is the polarization value at
100% inhibition, and P is the observed FP
at each concentration point. We used free
ES2 (100% inhibition) as a positive control
and ER–ES2 complex (0% inhibition) as a
negative control. We transformed polariza-
tion values into percent inhibition to nor-
malize the differences at 0% inhibition for
each run. We then analyzed the percent
inhibition versus competitor concentration
curves by nonlinear least-squares curve fit-
ting and determined the concentration of
competitor needed to displace half of the
bound ligand (IC50). To compare the bind-
ing afﬁnities of the tested phytoestrogens, we
converted IC50 values to relative binding
afﬁnities (RBA) using E2 as a standard. The
E2 RBA was set equal to 100, and the RBA
value for each of the phytoestrogens was cal-
culated using the following formula:
RBA = (IC50 E2/IC50 competitor) × 100.
ERE preparation. We tested ERE from
the Xenopus vit A2 gene, ERE from the
human pS2 gene, and consensus GRE to
bind ERα and ERβ (Table 1). The sense
DNA strands (Oligos Etc., Wilsonville, OR)
containing EREs and GRE were labeled with
ﬂuorescein attached via a 6-carbon spacer at
the 5´ terminus (22). The 35-base pair dou-
ble stranded oligonucleotides were prepared
by annealing equimolar concentrations of the
sense and antisense strands in 10 mM Tris-
HCl, pH 7.8, and 150 mM NaCl. This mix-
ture was heated to 95°C for 10 min and
slowly cooled (30 min) to room temperature.
To remove any hairpin formations, we puri-
ﬁed the double stranded DNA by using 12%
polyacrylamide (1:19 bisacrylamide:acry-
lamide) gel electrophoresis containing 89
mM Tris-borate; 2.5 mM EDTA, pH 8.3;
and 10% ammonium persulphate (23,24).
ER–ERE direct binding studies. To fur-
ther investigate the estrogenic properties of
the phytoestrogens, we performed direct
binding experiments and measured the abili-
ties of ERα and ERβ to associate with
Xenopus vit A2 ERE and human pS2 ERE in
the presence of phytoestrogens. ERα and
ERβ were serially diluted from 450 nM to 0.8
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Figure 1. Structures of 17β -estradiol and all dietary estrogens used in this study.
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OnM in DNA binding buffer (10 mM potassi-
um phosphate, pH 7.8; 0.1 mM EDTA; 50
µM magnesium chloride; 10% glycerol). We
incubated the ERs 30 min with concentra-
tions of each of the phytoestrogens required
to saturate ERα and ERβ as determined by
competitive binding experiments, and then
for 10 min with poly (dI-dC) (1 µg/5 µg of
protein) at room temperature. The binding,
initiated by adding ﬂuorescein-labeled syn-
thetic oligonucleotide EREs (ﬁnal concentra-
tion 0.5 nM), was allowed to proceed at room
temperature 60 min. The polarization values
of each ER concentration were then measured
on a Beacon 2000 instrument with 490 nm
excitation and 530 nm emission maximums.
We constructed the binding isotherm by plot-
ting percent saturation versus ER concentra-
tion using the formula
S% = (P–P0)/(P100–P0) × 100,
where P0 is the polarization value at 0% sat-
uration, P100 is the polarization value at
100% saturation, and P is the observed FP at
each concentration point. We calculated the
Kd from the binding curves using a nonlin-
ear least-squares curve ﬁtting program. The
binding afﬁnities of ERα and ERβ (liganded
with phytoestrogens) for EREs were also cal-
culated in terms of RBA [RBA = (Kd E2/Kd
competitor) × 100].
To prove the reliability and speciﬁcity of
the method, we compared the binding
affinities of ERα and ERβ (liganded with
E2) for fluorescein-labeled Xenopus vit A2
ERE and fluorescein-labeled GRE (Figure
2). At the concentration range tested, no
ER–GRE complexes were formed, as
opposed to the high afﬁnity binding of both
ERs to the consensus ERE.
Results
ERα and ERβ saturation with ES2. Figure 3
shows the curves of ES2 saturation binding to
recombinant human ERs. We titrated 1 nM
labeled ligand with increasing concentrations
of the ERs to produce these binding
isotherms. The Kd values calculated from the
saturation curves were 10 nM for ERβ and 25
nM for ERα . The afﬁnity of labeled ES2 lig-
and was 2-fold higher for ERβ than for ERα .
Binding affinities of several phytoestro-
gens for ERα and ERβ . We determined the
binding affinities of different classes of
phytoestrogens for ERα and ERβ in compe-
tition binding with the ER–ES2 complex.
We determined the binding afﬁnities (IC50
values) of the tested dietary estrogens from
the competition curves (Figure 4 and Table
2). Phytoestrogens compete with ES2 for
binding ERα in the following order: zear-
alenone > coumestrol > genistein > glyceollin
> daidzein; for ERβ : genistein > zearalenone >
coumestrol > daidzein > glyceollin (Table 2).
With the exception of glyceollin, the
afﬁnity of all the dietary estrogens tested is
much higher for ERβ than ERα . The binding
afﬁnity of genistein for ERβ is 60-fold higher
than its afﬁnity for ERα , whereas for coume-
strol and zearalenone, there is approximately a
3-fold difference (Table 2). Glyceollin was
found to have a 3-fold higher affinity for
ERα . E2 binds to ERα with an affinity
approximately 3-fold higher than genistein,
which has been previously observed (25).
Genistein binds with the same afﬁnity as E2
to ERβ . Zearalenone shows similar activity as
genistein and forms a complex with ERβ with
1.3-fold less afﬁnity than E2.
Phytoestrogen-dependent binding of ERα
and ERβ to two different EREs. All of the phy-
toestrogens promote less binding of ERα and
ERβ to Xenopus vit A2 ERE than does
E2(Table 3). Genistein and zearalenone cause
similar changes in the afﬁnity of both receptors
for this consensus ERE, which is approximate-
ly 2-fold lower than the effect of E2. We
observed approximately 2-fold higher afﬁnity
for the binding of the coumestrol–ERα com-
plex to Xenopus vit A2 ERE than for the bind-
ing of the coumestrol–ERβ complex. This is
also true for ER complexes with daidzein, but
daidzein–ERβ complex has almost 6-fold high-
er affinity than daidzein–ERα complex.
Glyceollin inhibits the formation of ER–ERE
complexes (Table 3).
The binding of ERα to human pS2 ERE
in the presence of E2 occurs with approxi-
mately 2.5-fold higher afﬁnity than the bind-
ing of ERβ in the presence of E2, (Kds of 32
nM and 84 nM, respectively). Zearalenone
produces high afﬁnity binding of both ERs
to human pS2 ERE, with zearalenone–ERβ
complex binding even more tightly than
E2–ERβ complex. Genistein is the only phy-
toestrogen we tested that causes a consider-
able difference in the binding of the ERα
and ERβ complexes to the human ERE. The
ERβ complex containing genistein has
approximately 2-fold lower afﬁnity than the
genistein–ERα complex.
We observed similar afﬁnity of ERα for
both EREs when ERα was liganded with E2,
but we found differential binding of ERα to
the EREs in the presence of the dietary
estrogens. Zearalenone, genistein, and
daidzein cause better binding of ERα to
human pS2 ERE as compared with Xenopus
vit A2 ERE. Coumestrol is the only phytoe-
strogen we tested that induces a higher afﬁn-
ity binding of ERα to the Xenopus vit A2
ERE (Table 3).
E2 promotes differential binding of ERβ
to the EREs, with 2.5-fold higher afﬁnity of
the E2–ERβ complex for Xenopus vit A2
ERE. The relative binding afﬁnities of ERβ
for both EREs are similar when the receptor
is liganded with coumestrol, genistein, and
daidzein. Zearalenone–ERβ complex differ-
entially binds to the EREs; the complex has
higher relative binding affinity for human
pS2 ERE than E2–ERβ .
The Kds and relative binding affinities
alone do not fully describe the interactions
Articles • Phytoestrogens binding to hERs and ER–ERE complex formation
Environmental Health Perspectives • VOLUME 108 | NUMBER 9 | September 2000 869
Table 1. Double stranded DNA sequences containing EREs and GRE.
Xenopus vit A2 ERE 5´ XGTC CAA AGT CA GGTCA CAG TGACC TGA TCA AAG TT 3´
3´ CAG GTT TCA GT CCAGT GTC ACTGG ACT AGT TTC AA 5´
Human pS2 ERE 5´ XGT CCA AAG TCA GGTCA CGG TGGCC TG ATC AAA GTT 3´
3´ CA GGT TTC AGT CCAGT GCC ACCGG AC TAG TTT CAA 5´
Consensus GRE 5´ XGT CCA AAG TCA GAACA CAG TGTTC TGATC AAA GTT 3´
3´ CA GGT TTC AGT CTTGT GTC ACAAG ACTAG TTT CAA 5´
bp, base pair. The underlined sequences represent the limits of the 13 bp reverse repeat of the EREs and the GRE that
contain 5 bp arms and a 3 bp spacer region. 
Figure 2. Binding of ER–E2 complexes to GRE and
Xenopus vit A2 ERE. mp, millipolarization. Data
points represent the mean percent saturation
value ± SEM from two different experiments. 
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Figure 3. The binding isotherms of human recom-
binant ERα and ERβ and ES2. mp, millipolariza-
tion. The ﬂuorescence of ES2 alone produces low
polarization values. Upon binding ER molecules,
the rotational freedom of the complex decreases
and higher polarization values are measured.
When all ES2 molecules are bound, further
increase in the ER concentration does not affect
the FP of the system. Data points represent the
mean polarization value ± SEM from two different
experiments.
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ERβ  Kd 10 nMof ERα and ERβ with the EREs, especially
at end point saturation concentrations
(Figure 5). The maximal effective molecular
volume of Xenopus vit A2 and human pS2
EREs varies with the ER–phytoestrogen
complex present. The difference is more pro-
found with ERβ than with ERα (Figure 6).
Coumestrol and genistein trigger similar
changes in ERβ , which result in different
effective molecular volumes of the labeled
response elements. ERβ liganded with either
of the two phytoestrogens triggers 50%
faster rotational motion (decreased molecu-
lar volume) of Xenopus vit A2 ERE than the
rotational motion of this ERE in the pres-
ence of the ERβ –E2 complex. The speed of
rotation of human pS2 ERE in the presence
of ERβ –genistein complex or ERβ –coume-
strol complex is decreased to approximately
50% (increased molecular volume) from its
rotational motion with ERβ –E2 complex
present (Figure 6). We also observed the
same pattern with ERα , but the differences
at end point saturation concentrations are
not as signiﬁcant as with ERβ .
Discussion
We used the FP method to study the inter-
actions of several phytoestrogens with
human ERα and ERβ and their effects on
ER–ERE complex formation. This approach
allows detection of ligand–receptor and
receptor–response element interactions in
solution (without solid supports) and 
at room temperature. The information
obtained can be analyzed by nonlinear least-
squares curve fitting to yield the binding
constants of these interactions.
In several epidemiologic studies, a rela-
tionship between the intake of soy foods and
reduced breast or prostate cancer has been
suggested (26–30), and one of the proposed
mechanisms involves activation of transcrip-
tion through the ERs. In our studies, we used
recombinant human ERs and labeled E2 to
compare the afﬁnities of different classes of
phytoestrogens to bind ERα and ERβ . The
isoﬂavone genistein, the coumestan coume-
strol, and the resorcylic acid lactone zear-
alenone have greater afﬁnity for both receptors
than daidzein and glyceollin (Figure 4).
This can be explained by the size of the
binding cavity of the ER, which has a volume
almost twice that of the E2 molecule. The
length and the width of the E2 skeleton are
very well matched by the receptor’s ligand
binding domain, but there are large unoccu-
pied spaces opposite the B-ring and the C-
ring of E2 (31). Previous studies found that
coumestrol has the highest afﬁnity for both
receptors (25), but this was not conﬁrmed by
our competitive binding experiments. These
FP competition binding experiments were
performed at room temperature and the phy-
toestrogens were incubated with the ER–ES2
complex for 2 hr, whereas in the competition
binding method described by Kuiper et al.
(25), the phytoestrogens were incubated with
3H-E2–ER complex for 18–20 hr at 6°C.
These differences in binding times and tem-
peratures, and the fact that we used an E2S
with an increased molecular volume instead
of 3H-E2, may account for the different rela-
tive binding afﬁnities that we observed. The
FP measurements also indicate that genistein
has greater binding affinity for ERβ than
does coumestrol, whereas zearalenone has
greater binding afﬁnity for ERα (Table 2).
We observed differential binding of the
dietary estrogens to the receptor proteins. FP
indicates that genistein binds ERβ with the
same afﬁnity as E2 and has low relative bind-
ing affinity for ERα . Differences in the
binding to both human receptors were also
observed with zearalenone and coumestrol.
This differential binding may suggest tissue-
specific biologic effects triggered by the
dietary estrogens because both ER subtype
transcripts were found in breast and prostate
tumor tissues, but with different expression
levels (32,33).
To better understand the influence of
the dietary estrogens on ER–ERE complex
formation, we compared the relative binding
affinities of the receptor proteins liganded
with phytoestrogens for the consensus ERE
derived from Xenopus vit A2 gene and a
human pS2 ERE (Table 1). ERα saturated
with any of the phytoestrogens has lower
affinity for both EREs than ERα liganded
with E2. Coumestrol promotes the highest
affinity of ERα for Xenopus vit A2 ERE,
approximately 1.5-fold less than the effect
triggered by E2. The same phytoestrogens
differentially affect the binding of ERα to
human pS2 ERE, and zearalenone inﬂuences
binding with a magnitude almost as potent as
E2 (Table 3). We found that phytoestrogens
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Figure 4. Competition binding curves of various dietary estrogens for (A) ERα –ES2 and (B) ERβ –ES2 com-
plexes. The initial ER–ES2 complexes have high polarization values. When the complex is titrated with
competitors, ES2 molecules are displaced from the ER and there is a gradual decrease in the polarization
values. Data points represent the mean percent inhibition value ± SEM from two different experiments.
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Table 2. RBAs and IC50 constants of tested dietary estrogens for human ERα and ERβ from competition
experiments.
ERα ERβ
Compound IC50 RBA IC50 RBA
E2 13 ± 0.7 nM 100 12 ± 0.5 nM 100
Genistein 825 ± 2 nM  1.6 12 ± 0.7 nM 100
Coumestrol 109 ± 1 nM  12 35 ± 0.7 nM 34
Zearalenone 59 ± 0.8 nM 22 16 ± 0.5 nM 75
Daidzein 7 ± 1 µM 0.2 670 ± 1 nM 1.8
Glyceollin 6 ± 0.6 µM 0.22 16 ± 1.4 µM 0.08
Testosterone 35 ± 0.5 µM  0.04 20 ± 1 µM 0.06
The RBA of each competitor was calculated as a ratio of the IC50 values of each competitor and E2. The RBA value of E2
was arbitrarily set at 100. The data represent the mean IC50 values ± SEM from two different experiments.
Table 3. Kd constants and (RBAs) of ERα and ERβ (saturated with phytoestrogens) for Xenopus vit A2 and
human pS2 EREs.
Xenopus vit A2 ERE Human pS2 ERE
Compound ERα ERβ ERα ERβ
E2 32 nM (100) 34 nM (100) 32 nM (100) 84 nM (100)
Genistein 57 nM (56) 70 nM (49) 42 nM (76) 212 nM (40)
Coumestrol 45 nM (71) 97 nM (35) 75 nM (43) 218 nM (39)
Zearalenone 57 nM (56) 69 nM (49) 34 nM (94) 70 nM (120)
Daidzein 209 nM (15) 40 nM (85) 50 nM (67) 118 nM (71)
Glyceollin – (< 0.01) – (< 0.01) – (< 0.01) – (< 0.01)
The RBA of each ER saturated with competitor was calculated as a ratio of the Kd values of each competitor and E2. The
RBA values of the ERs saturated with E2 were arbitrarily set at 100.have similar effects on the relative binding
affinities of ERβ to the vit A2 and pS2
response elements, and only zearalenone
causes differences in the binding of the
receptor to the EREs. The data suggest that,
upon binding those structurally different
phytoestrogens, the receptor proteins under-
go conformational changes, which differen-
tially affect the formation of the ER–ERE
complexes. The dietary estrogens apparently
induce distinct conformational changes in
ERα and ERβ , as have been previously
observed with other ER ligands (34).
Apart from the relative binding afﬁnities
of the ERs for the response elements, the
changes in the effective molecular volume of
the Xenopus vit A2 and the human pS2
response elements triggered by different
ERβ –phytoestrogen complexes (Figure 6)
provide additional information about the
interactions of the receptor proteins with
DNA. The molecular volume of Xenopus vit
A2 ERE complexed with ERβ –genistein or
with ERβ –coumestrol is only about half the
effective molecular volume of the complex of
this ERE with ERβ –E2. The molecular vol-
ume of human pS2 ERE is also affected by
ERβ –genistein and ERβ –coumestrol com-
plexes; it is approximately 1.5-fold higher
than the molecular volume of human pS2
ERE complexed with ERβ –E2 (Figure 6). We
do not yet know the exact reason for the
high polarization values (decreased speed of
rotation of the labeled molecule) due to the
binding of ERβ –genistein/coumestrol to
human pS2 ERE at high protein concentra-
tions. Because the FP depends on the rota-
tional freedom of the ﬂuorescent molecule,
especially the ﬂuorescence label (17,19), it is
possible that binding of the receptor pro-
tein–phytoestrogen complex changes the
geometry of the labeled DNA molecule, for
example, by increasing the bending of the
DNA chain or by causing a partial unwind-
ing (loosening) of the end of the DNA that
is labeled with ﬂuorescein. The data, howev-
er, clearly demonstrate that phytoestrogens
affect differentially the ER–ERE interac-
tions. Based on these ﬁndings we conclude
that phytoestrogens interact with the
human ERs in a manner that influences
both the formation and the physical proper-
ties of ER–ERE complexes. We were able to
detect these differences in ER–ERE com-
plex formation using EREs from Xenopus
vit A2 and human pS2 genes that differ with
only one base pair (Table 1). Functional
and nonfunctional EREs with one or two
base pair differences can be found in many
genes (35), and differences in the conforma-
tion of the ERs complexes with xenoestro-
gens may cause transformations of different
functional EREs into nonfunctional ones
and vice versa.
Kinetics of the frequency of ER–DNA
interactions in the presence of different ER
ligands have been studied by Cheskis et al.
(36). They found that ligand binding affects
the kinetics of human ERα interaction with
Xenopus vit A2 ERE. They also found that
E2 induces rapid formation of an unstable
ER–ERE complex, whereas binding of
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Figure 5. Binding of human recombinant ERα and ERβ (saturated with various phytoestrogens) to (A) ﬂuo-
rescein-labeled Xenopus vit A2 ERE, and (B) ﬂuorescein-labeled human pS2 ERE. Data points represent
the mean percent saturation value ± SEM from two different experiments.
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Figure 6. Speed of rotation (represented as polarization values) of the labeled consensus and nonconsen-
sus EREs in the presence of (A) human recombinant ERβ and (B) human recombinant ERα , both liganded
with E2 and various phytoestrogens. mp, millipolarization. The speed of rotation of each of the EREs com-
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Human pS2 ERE Xenopus vit A2 ERE“pure” antagonist such as ICI 182,780 results
in a slow formation of a very stable recep-
tor–DNA complex. Cheskis et al. (36) con-
cluded that the kinetics of ligand binding to
EREs were correlated with the observed bio-
logic activities of the ligands. Our data also
support the view that ligand binding may
induce conformational changes that not only
modulate the interactions of ER with other
transcriptional factors but directly affect the
physical properties of ER–ERE complexes.
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